Drawing for HTL BIOTECHNOLOGY

USPTO serial 79346473

HTL BIOTECHNOLOGY

Reviewed by CopyMark Law Group

Reg. 7341551Status 700Registered
Filing date
Status date
Registration date
Apr 2, 2024
Examiner
BARRETT, LEAH N
Law office
TMEG LAW OFFICE 106

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HTL BIOTECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Philip Conrad

Philip Conrad Decode Legal Inc.560 CREMAZIE EST, SUITE 300MONTREAL, H2P1E8CANADA

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; chemical raw materials in the nature of biopolymers for use in industry and scienceACTIVE—
003Cosmetic preparations for skin care, skin tanning, for slimming purposes; cosmetic preparations for nail, hair and teeth careACTIVE—
005Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment of dermatological, rheumatological, ophthalmological diseases, disorders and conditions, and for use in regenerative medicine and for treatment or augmentation of bone and tissue; chemical preparations for medical and veterinary use, namely, for the treatment of dermatological, rheumatological, ophthalmological diseases, disorders and conditions, and for use in regenerative medicine and for treatment or augmentation of bone and tissueACTIVE—
042Industrial analysis and research in the field of pharmaceutical products, healthcare products, cosmetic products and medical devices containing hyaluronic acid and derivatives, and other biopolymers of medical or cosmetic interest; research and development of new products for third partiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 8, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 8, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 2, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 16, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 16, 2024FIMPFINAL DISPOSITION PROCESSED—
Jul 3, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 2, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 2, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 29, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 13, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jan 10, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 10, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 27, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 11, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Dec 11, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 11, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 11, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2023RFNPREFUSAL PROCESSED BY IB—
May 11, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 10, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 22, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 21, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2023DOCKASSIGNED TO EXAMINER—
Aug 9, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 5, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance